---
$id: https://graph.org.ai/products/commodity/51361902
$type: Product
source: UNSPSC
code: "51361902"
title: "Allobarbital"
class: "51361900"
classTitle: "Hypnotic barbiturates"
family: "51360000"
familyTitle: "Hypnotics"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Allobarbital

**UNSPSC Code**: 51361902
**Class**: [Hypnotic barbiturates](Hypnotic barbiturates.mdx)
**Family**: [Hypnotics](../Hypnotics.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a barbiturate with the molecular formula C10H12N2O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 8NT43GG2HA, chemically known as 2,4,6(1h,3h,5h)-pyrimidinetrione, 5,5-di-2-propenyl- but generally known as allobarbital, which bears US NIH Compound Identifier 5842. Allobarbital comes in forms base, epoxide, and sodium. European Medicines Agency schedules Allobarbital in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05334MIG. The term ALLOBARBITAL is an International Non-Proprietary Name. World Health Organization schedules allobarbital in its Anatomical Therapeutic Chemical (ATC) Classification. ALLOBARBITAL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule allobarbital under HS 29335390 and SITC 51576. As of Q4 2014, ALLOBARBITAL remains the US FDA Preferred Term for this commodity. Allobarbital bears US NLM identifiers UMLS ID C0002132 and NCI Concept Code C76522. SMILES: C=CCC1(C(=O)NC(=O)NC1=O)CC=C.

